Literature DB >> 32554924

TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women.

Pascal Azar1, José Enrique Mejía1, Claire Cenac1, Arnoo Shaiykova2, Ali Youness1, Sophie Laffont1, Asma Essat2, Jacques Izopet1,3, Caroline Passaes4, Michaela Müller-Trutwin4, Pierre Delobel1,5, Laurence Meyer2, Jean-Charles Guéry1.   

Abstract

Type I IFN (IFN-I) production by plasmacytoid DCs (pDCs) occurs during acute HIV-1 infection in response to TLR7 stimulation, but the role of pDC-derived IFN-I in controlling or promoting HIV-1 infection is ambiguous. We report here a sex-biased interferogenic phenotype for a frequent single-nucleotide polymorphism of human TLR7, rs179008, displaying an impact on key parameters of acute HIV-1 infection. We show allele rs179008 T to determine lower TLR7 protein abundance in cells from women, specifically - likely by diminishing TLR7 mRNA translation efficiency through codon usage. The hypomorphic TLR7 phenotype is mirrored by decreased TLR7-driven IFN-I production by female pDCs. Among women from the French ANRS PRIMO cohort of acute HIV-1 patients, carriage of allele rs179008 T associated with lower viremia, cell-associated HIV-1 DNA, and CXCL10 (IP-10) plasma concentrations. RNA viral load was decreased by 0.85 log10 (95% CI, -1.51 to -0.18) among T/T homozygotes, who also exhibited a lower frequency of acute symptoms. TLR7 emerges as an important control locus for acute HIV-1 viremia, and the clinical phenotype for allele rs179008 T, carried by 30%-50% of European women, supports a beneficial effect of toning down TLR7-driven IFN-I production by pDCs during acute HIV-1 infection.

Entities:  

Keywords:  AIDS/HIV; Immunology; Innate immunity

Mesh:

Substances:

Year:  2020        PMID: 32554924      PMCID: PMC7406249          DOI: 10.1172/jci.insight.136047

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  64 in total

1.  Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

Authors:  Jean-Philippe Herbeuval; Jakob Nilsson; Adriano Boasso; Andrew W Hardy; Michael J Kruhlak; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Jan Andersson; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

2.  A role for tRNA modifications in genome structure and codon usage.

Authors:  Eva Maria Novoa; Mariana Pavon-Eternod; Tao Pan; Lluís Ribas de Pouplana
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

3.  The molecular structure of the left-handed supra-molecular helix of eukaryotic polyribosomes.

Authors:  Alexander G Myasnikov; Zhanna A Afonina; Jean-François Ménétret; Vladimir A Shirokov; Alexander S Spirin; Bruno P Klaholz
Journal:  Nat Commun       Date:  2014-11-07       Impact factor: 14.919

4.  HIV: The mixed blessing of interferon.

Authors:  Amalio Telenti
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

5.  TLR7 induces anergy in human CD4(+) T cells.

Authors:  Margarita Dominguez-Villar; Anne-Sophie Gautron; Marine de Marcken; Marla J Keller; David A Hafler
Journal:  Nat Immunol       Date:  2014-11-17       Impact factor: 25.606

6.  Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens.

Authors:  Victoria J Philbin; Muhammad Iqbal; Yvonne Boyd; Marianne J Goodchild; Richard K Beal; Nat Bumstead; John Young; Adrian L Smith
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

7.  Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection.

Authors:  M von Sydow; A Sönnerborg; H Gaines; O Strannegård
Journal:  AIDS Res Hum Retroviruses       Date:  1991-04       Impact factor: 2.205

8.  Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

Authors:  Diana V Pastrana; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Philip E Castle; Peter C FitzGerald; Susanne Krüger Kjaer; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

9.  A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.

Authors:  Djin-Ye Oh; Konstantin Baumann; Osamah Hamouda; Jana K Eckert; Konrad Neumann; Claudia Kücherer; Barbara Bartmeyer; Gabriele Poggensee; Nari Oh; Axel Pruss; Heiko Jessen; Ralf R Schumann
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

10.  Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense.

Authors:  Luis B Barreiro; Meriem Ben-Ali; Hélène Quach; Guillaume Laval; Etienne Patin; Joseph K Pickrell; Christiane Bouchier; Magali Tichit; Olivier Neyrolles; Brigitte Gicquel; Judith R Kidd; Kenneth K Kidd; Alexandre Alcaïs; Josiane Ragimbeau; Sandra Pellegrini; Laurent Abel; Jean-Laurent Casanova; Lluís Quintana-Murci
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

View more
  8 in total

Review 1.  Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis.

Authors:  Manish Gupta; Geetha Srikrishna; Sabra L Klein; William R Bishai
Journal:  Trends Immunol       Date:  2022-07-13       Impact factor: 19.709

2.  Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection.

Authors:  Caroline Passaes; Héloïse M Delagreverie; Véronique Avettand-Fenoel; Annie David; Valérie Monceaux; Asma Essat; Michaela Müller-Trutwin; Darragh Duffy; Nathalie De Castro; Linda Wittkop; Christine Rouzioux; Jean-Michel Molina; Laurence Meyer; Constance Delaugerre; Asier Sáez-Cirión
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 3.  Escape from X Chromosome Inactivation and the Female Predominance in Autoimmune Diseases.

Authors:  Ali Youness; Charles-Henry Miquel; Jean-Charles Guéry
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

Review 4.  Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.

Authors:  Jamie A Sugrue; Nollaig M Bourke; Cliona O'Farrelly
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

5.  Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.

Authors:  Anna E Spiering; Teun J de Vries
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

6.  Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism.

Authors:  Natália Lima Pessoa; Aline Almeida Bentes; Andrea Lucchesi de Carvalho; Thaís Bárbara de Souza Silva; Pedro Augusto Alves; Erik Vinicius de Sousa Reis; Tayse Andrade Rodrigues; Erna Geessien Kroon; Marco Antônio Campos
Journal:  Virol J       Date:  2021-09-05       Impact factor: 4.099

Review 7.  Sex Differences in Primary HIV Infection: Revisiting the Role of TLR7-Driven Type 1 IFN Production by Plasmacytoid Dendritic Cells in Women.

Authors:  Jean-Charles Guéry
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

8.  Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study.

Authors:  Eteri Regis; Sara Fontanella; Adnan Custovic; Sebastian L Johnston; Lijing Lin; Rebecca Howard; Sadia Haider; John A Curtin; Michael R Edwards; Magnus Rattray; Angela Simpson
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.